The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis

BACKGROUND: Osteoporosis is a metabolic bone disease. Bisphosphonate (BP) and eldecalcitol (ELD) are two clinical first-line drugs for osteoporosis patients. However, the effect of ELD + BP vs. BP alone on osteoporosis treatment is still unclear. The present meta-analysis was conducted to evaluate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zaoqian, Luo, Jinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487739/
https://www.ncbi.nlm.nih.gov/pubmed/32907639
http://dx.doi.org/10.1186/s13018-020-01896-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487739/
https://www.ncbi.nlm.nih.gov/pubmed/32907639
http://dx.doi.org/10.1186/s13018-020-01896-z

Ejemplares similares